The effectiveness of social resource intervention to promote adherence to HIV medication in a multidisciplinary care setting in Kenya

International Journal of STD and AIDS

Volumn 23, Issue 12, 2012, Pages 843-848

  Kamau, T M ^a   Olsen, V G ^b   Zipp, G P ^c   Clark, M ^d  

^a OHIO UNIVERSITY   (United States)

^b Dominican College   (United States)

^c SETON HALL UNIVERSITY   (United States)

^d LONG ISLAND UNIVERSITY   (United States)

Author keywords

Adherence; Africa; AIDS; Antiretroviral therapy; Dimensions of support; HIV; HIV medication; Social support

Indexed keywords

ADULT; ARTICLE; EMOTION; FEMALE; HEALTH CARE; HEALTH PERSONNEL ATTITUDE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL SUPPORT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; KENYA; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS;

EID: 84871686956     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2012.011472     Document Type: Article

References (32)

1. United Nations Program on HIV/AIDS & World Health Organization (UNAIDS). Epidemic Updates. December 2009. See http://www.unaids.org/ en/Dataanalysis/Epidemiology/2009AIDSEpidemicUpdate (last checked 30 November 2011)
2. World Health Organization (WHO). Country Fact Sheet. 2006. See http://www. who.int/countries/ken/en (last checked 19 September 2011)
3. Kenya National AIDS Control Council (NACC). See http://nascop.or.ke/ library/3d/Official_KAIS_Report_20091.pdf (last checked 20 September 2011)
4. Laurent C, Ngom G, Ndeye F, et al. Long term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. J Acquir Immune Defic Syndr 2005;38:14-7
5. Bangsberg DR, Kroetz DL, Deeks SG. Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep 2007;42:65-72
6. Paterson DL, Swindells S, Mohr J, Brester M. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30
7. Bangsberg DR. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis 2008;197(Suppl. 3):S272-278
8. Garcia R, Schooley TR, Badaro R. An adherence trilogy is essential for long-term HAART success. Braz J Infect Dis 2003;7:307-14
9. Lewis MP, Colbert A, Erlen J, Meyers M. A qualitative study of persons who are 100% adherent to antiretroviral therapy. AIDS Care 2006;18:140-8
10. Johnson A, Witt H. Adherence to ART Practices in Resource-Constrained Settings. Submitted to the US Agency for International Development by the Rational Pharmaceutical Management Plus Program. Arlington, VA: Management Sciences for Health, 2007
11. Cohen S. Psychosocial models of social support in the etiology of physical disease. Health Psychol 1998;7:269-97
12. Cohen S, Hoberman H. Positive events and social supports as buffers of life change stress. J Appl Psychol 1983;13:99-125
13. Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull 1985;98:310-57
14. Simoni JM, Frick PA, Lockart D, Liebovitz D. Mediators of social support and antiretroviral adherence among an indigent population in New York City. AIDS Patient Care STDS 2002;16:43-439
15. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 2004;32:207-18
16. Gonzalez JS, Penedo FJ, Antoni MH, et al. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV. Health Psychol 2004;23:413-8
17. Williams AB, Fennie KP, Bova CA, et al. Home visits to improve adherence to highly active ART: a randomized controlled trial. J Acquir Immune Defic Syndr 2006;43:314-21
18. National Institute of Mental Health (NIH) Office of Extramural Research. Protecting HumanResearch Participants. See http://phrp.nihtraining.com/users/ login.php (last checked 29 November 11)
19. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Wu AW. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: AACTG adherence instruments. AIDS Care 2000;12:255-66
20. Liu H, Beck CK, Golin CE, Hays RD, Miller LG. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134:968-77
21. Nieuwkerk PT, Oort F. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr 2005;38:445-8
22. Fairley CK, Levy R, Rayner CR, et al. Randomized trial of an adherence programme for patients with HIV. Int J STD AIDS 2003;14:805-9
23. Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2001;26:82-92
24. Unge C, Sodergard B, Marrone G, Thorson A, Lukharo A. Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in Sub-Saharan Africa: a prospective cohort study. PloS One 2010;5:e13613
25. Tabachnick NG, Fidell LS. Using Mutivariate Statistics. 4th edn. Boston: Allyn and Bacon, 2001
26. Munro BH. Statistical Methods for Healthcare Research. 5th edn. New York: Lippencott Williams & Wilkins, 2005
27. Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, et al. Adherence to HIV ART in HIV{thorn} Ugandan patients purchasing therapy. Int J STD AIDS 2005;16:41
28. Mills EJ, Nachega JB, Buchan I, et al. Adherence to ART in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006;296:679-90
29. Frick P, Tapia K, Grant P, Novotny M, Kerzee J. The effect of a multidisciplinary program on HAART adherence. AIDS Patient Care STDS 2006;20:511-24
30. Friedland GH. HIV medication adherence. The intersection of biomedical, behavioral, and social science research and clinical practice. J Acquir Immune Defic Syndr 2006;43(Suppl. 1):S3-9
31. Wainberg M, Martinez-Cajas J, Brenner B. Strategies for the optimal sequencing of antiretroviral drugs toward overcoming and preventing drug resistance. Futur HIV Ther 2007;1:291-313
32. Ministry of Health. Taking the Kenya Essential Package for Health to the Community: A Strategy for the Delivery of Level One Services. Nairobi, Kenya: Health Sector Reform Secretariat, 2006